FilingIndex
DEF 14AThe Ballot

BridgeBio Pharma, Inc. files DEF 14A

Filed Apr 28, 2023 · 3y ago · Accession 0001193125-23-127256

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
BBIO
CIK
1743881
Form type
DEF 14A
Filing date
Apr 28, 2023
Report date
Document
d438976ddef14a.htm
Size
3.8 MB